nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—Leflunomide—systemic lupus erythematosus	0.165	0.261	CbGbCtD
Riluzole—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.102	0.161	CbGbCtD
Riluzole—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0818	0.129	CbGbCtD
Riluzole—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0773	0.122	CbGbCtD
Riluzole—CYP1A2—Leflunomide—systemic lupus erythematosus	0.068	0.108	CbGbCtD
Riluzole—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0509	0.0804	CbGbCtD
Riluzole—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.047	0.0742	CbGbCtD
Riluzole—ABCG2—Methotrexate—systemic lupus erythematosus	0.0409	0.0646	CbGbCtD
Riluzole—SLC7A11—Amino acid and oligopeptide SLC transporters—SLC15A4—systemic lupus erythematosus	0.00105	0.124	CbGpPWpGaD
Riluzole—SLC7A11—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.000621	0.0729	CbGpPWpGaD
Riluzole—SLC7A11—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.000577	0.0912	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.000577	0.0912	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000545	0.0861	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000545	0.0861	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.000536	0.0847	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.000536	0.0847	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Triamcinolone—systemic lupus erythematosus	0.000524	0.0828	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Triamcinolone—systemic lupus erythematosus	0.000524	0.0828	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Prednisone—systemic lupus erythematosus	0.000497	0.0785	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Prednisone—systemic lupus erythematosus	0.000497	0.0785	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Prednisolone—systemic lupus erythematosus	0.000485	0.0767	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Prednisolone—systemic lupus erythematosus	0.000485	0.0767	CbGdCrCtD
Riluzole—CYP1A2—Arylamine metabolism—NAT2—systemic lupus erythematosus	0.000402	0.0472	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—ITGAX—systemic lupus erythematosus	0.000306	0.0359	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000278	0.0326	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—SELE—systemic lupus erythematosus	0.000243	0.0285	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—ITGAM—systemic lupus erythematosus	0.000229	0.0268	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—LYN—systemic lupus erythematosus	0.000221	0.0259	CbGpPWpGaD
Riluzole—CYP1A2—urine—systemic lupus erythematosus	0.000193	0.164	CbGeAlD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000185	0.0217	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.000148	0.0174	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.000148	0.0174	CbGpPWpGaD
Riluzole—SLC7A11—kidney—systemic lupus erythematosus	0.000144	0.122	CbGeAlD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000141	0.0166	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.00014	0.0165	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.000118	0.0138	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000112	0.0132	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—JUNB—systemic lupus erythematosus	0.000111	0.0131	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000109	0.0127	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—F2—systemic lupus erythematosus	0.000105	0.0123	CbGpPWpGaD
Riluzole—SLC7A11—lung—systemic lupus erythematosus	0.000102	0.0868	CbGeAlD
Riluzole—CYP1A2—blood plasma—systemic lupus erythematosus	0.000101	0.0856	CbGeAlD
Riluzole—SLC7A11—nervous system—systemic lupus erythematosus	9.44e-05	0.0803	CbGeAlD
Riluzole—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	9.1e-05	0.000259	CcSEcCtD
Riluzole—SLC7A11—central nervous system—systemic lupus erythematosus	9.09e-05	0.0773	CbGeAlD
Riluzole—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	9.08e-05	0.000259	CcSEcCtD
Riluzole—Pain—Hydrocortisone—systemic lupus erythematosus	9.07e-05	0.000258	CcSEcCtD
Riluzole—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	9.06e-05	0.000258	CcSEcCtD
Riluzole—Oedema—Betamethasone—systemic lupus erythematosus	9.06e-05	0.000258	CcSEcCtD
Riluzole—Oedema—Dexamethasone—systemic lupus erythematosus	9.06e-05	0.000258	CcSEcCtD
Riluzole—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	9.06e-05	0.000258	CcSEcCtD
Riluzole—Insomnia—Triamcinolone—systemic lupus erythematosus	9.03e-05	0.000257	CcSEcCtD
Riluzole—Insomnia—Methylprednisolone—systemic lupus erythematosus	9.01e-05	0.000257	CcSEcCtD
Riluzole—Infection—Betamethasone—systemic lupus erythematosus	9e-05	0.000256	CcSEcCtD
Riluzole—Infection—Dexamethasone—systemic lupus erythematosus	9e-05	0.000256	CcSEcCtD
Riluzole—Ill-defined disorder—Prednisone—systemic lupus erythematosus	8.97e-05	0.000255	CcSEcCtD
Riluzole—Paraesthesia—Triamcinolone—systemic lupus erythematosus	8.97e-05	0.000255	CcSEcCtD
Riluzole—Feeling abnormal—Prednisolone—systemic lupus erythematosus	8.95e-05	0.000255	CcSEcCtD
Riluzole—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	8.95e-05	0.000255	CcSEcCtD
Riluzole—Anaemia—Prednisone—systemic lupus erythematosus	8.94e-05	0.000254	CcSEcCtD
Riluzole—Shock—Betamethasone—systemic lupus erythematosus	8.92e-05	0.000254	CcSEcCtD
Riluzole—Shock—Dexamethasone—systemic lupus erythematosus	8.92e-05	0.000254	CcSEcCtD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	8.91e-05	0.0105	CbGpPWpGaD
Riluzole—Dyspnoea—Triamcinolone—systemic lupus erythematosus	8.9e-05	0.000254	CcSEcCtD
Riluzole—Nervous system disorder—Betamethasone—systemic lupus erythematosus	8.89e-05	0.000253	CcSEcCtD
Riluzole—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	8.89e-05	0.000253	CcSEcCtD
Riluzole—Agitation—Prednisone—systemic lupus erythematosus	8.89e-05	0.000253	CcSEcCtD
Riluzole—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	8.87e-05	0.000253	CcSEcCtD
Riluzole—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	8.87e-05	0.000253	CcSEcCtD
Riluzole—Tachycardia—Betamethasone—systemic lupus erythematosus	8.85e-05	0.000252	CcSEcCtD
Riluzole—Tachycardia—Dexamethasone—systemic lupus erythematosus	8.85e-05	0.000252	CcSEcCtD
Riluzole—Angioedema—Prednisone—systemic lupus erythematosus	8.84e-05	0.000252	CcSEcCtD
Riluzole—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	8.79e-05	0.00025	CcSEcCtD
Riluzole—Dyspepsia—Triamcinolone—systemic lupus erythematosus	8.79e-05	0.00025	CcSEcCtD
Riluzole—Erythema multiforme—Methotrexate—systemic lupus erythematosus	8.78e-05	0.00025	CcSEcCtD
Riluzole—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	8.77e-05	0.00025	CcSEcCtD
Riluzole—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	8.76e-05	0.000249	CcSEcCtD
Riluzole—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	8.76e-05	0.000249	CcSEcCtD
Riluzole—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	8.74e-05	0.000249	CcSEcCtD
Riluzole—Malaise—Prednisone—systemic lupus erythematosus	8.72e-05	0.000248	CcSEcCtD
Riluzole—Vertigo—Prednisone—systemic lupus erythematosus	8.69e-05	0.000247	CcSEcCtD
Riluzole—Eye disorder—Methotrexate—systemic lupus erythematosus	8.68e-05	0.000247	CcSEcCtD
Riluzole—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	8.67e-05	0.000247	CcSEcCtD
Riluzole—Syncope—Prednisone—systemic lupus erythematosus	8.67e-05	0.000247	CcSEcCtD
Riluzole—Anorexia—Dexamethasone—systemic lupus erythematosus	8.64e-05	0.000246	CcSEcCtD
Riluzole—Anorexia—Betamethasone—systemic lupus erythematosus	8.64e-05	0.000246	CcSEcCtD
Riluzole—Urticaria—Prednisolone—systemic lupus erythematosus	8.63e-05	0.000246	CcSEcCtD
Riluzole—Cardiac disorder—Methotrexate—systemic lupus erythematosus	8.62e-05	0.000245	CcSEcCtD
Riluzole—Fatigue—Triamcinolone—systemic lupus erythematosus	8.61e-05	0.000245	CcSEcCtD
Riluzole—Fatigue—Methylprednisolone—systemic lupus erythematosus	8.59e-05	0.000245	CcSEcCtD
Riluzole—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	8.58e-05	0.000244	CcSEcCtD
Riluzole—Asthenia—Cyclosporine—systemic lupus erythematosus	8.56e-05	0.000244	CcSEcCtD
Riluzole—Pain—Triamcinolone—systemic lupus erythematosus	8.54e-05	0.000243	CcSEcCtD
Riluzole—Loss of consciousness—Prednisone—systemic lupus erythematosus	8.5e-05	0.000242	CcSEcCtD
Riluzole—Hypotension—Betamethasone—systemic lupus erythematosus	8.47e-05	0.000241	CcSEcCtD
Riluzole—Hypotension—Dexamethasone—systemic lupus erythematosus	8.47e-05	0.000241	CcSEcCtD
Riluzole—Pruritus—Cyclosporine—systemic lupus erythematosus	8.44e-05	0.00024	CcSEcCtD
Riluzole—Urticaria—Hydrocortisone—systemic lupus erythematosus	8.43e-05	0.00024	CcSEcCtD
Riluzole—Angiopathy—Methotrexate—systemic lupus erythematosus	8.42e-05	0.00024	CcSEcCtD
Riluzole—Immune system disorder—Methotrexate—systemic lupus erythematosus	8.39e-05	0.000239	CcSEcCtD
Riluzole—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	8.39e-05	0.000239	CcSEcCtD
Riluzole—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	8.39e-05	0.000239	CcSEcCtD
Riluzole—Convulsion—Prednisone—systemic lupus erythematosus	8.38e-05	0.000239	CcSEcCtD
Riluzole—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	8.37e-05	0.000238	CcSEcCtD
Riluzole—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	8.35e-05	0.000238	CcSEcCtD
Riluzole—Hypertension—Prednisone—systemic lupus erythematosus	8.35e-05	0.000238	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	8.34e-05	0.00979	CbGpPWpGaD
Riluzole—Chills—Methotrexate—systemic lupus erythematosus	8.33e-05	0.000237	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—ITGAX—systemic lupus erythematosus	8.3e-05	0.00974	CbGpPWpGaD
Riluzole—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	8.26e-05	0.000235	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	8.26e-05	0.000235	CcSEcCtD
Riluzole—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	8.24e-05	0.000235	CcSEcCtD
Riluzole—Myalgia—Prednisone—systemic lupus erythematosus	8.23e-05	0.000234	CcSEcCtD
Riluzole—Arthralgia—Prednisone—systemic lupus erythematosus	8.23e-05	0.000234	CcSEcCtD
Riluzole—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	8.23e-05	0.000234	CcSEcCtD
Riluzole—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	8.21e-05	0.000234	CcSEcCtD
Riluzole—Anxiety—Prednisone—systemic lupus erythematosus	8.2e-05	0.000234	CcSEcCtD
Riluzole—Alopecia—Methotrexate—systemic lupus erythematosus	8.2e-05	0.000234	CcSEcCtD
Riluzole—Insomnia—Betamethasone—systemic lupus erythematosus	8.2e-05	0.000233	CcSEcCtD
Riluzole—Insomnia—Dexamethasone—systemic lupus erythematosus	8.2e-05	0.000233	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—F3—systemic lupus erythematosus	8.18e-05	0.0096	CbGpPWpGaD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	8.18e-05	0.000233	CcSEcCtD
Riluzole—Diarrhoea—Cyclosporine—systemic lupus erythematosus	8.17e-05	0.000233	CcSEcCtD
Riluzole—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	8.15e-05	0.000232	CcSEcCtD
Riluzole—Paraesthesia—Dexamethasone—systemic lupus erythematosus	8.14e-05	0.000232	CcSEcCtD
Riluzole—Paraesthesia—Betamethasone—systemic lupus erythematosus	8.14e-05	0.000232	CcSEcCtD
Riluzole—Discomfort—Prednisone—systemic lupus erythematosus	8.13e-05	0.000232	CcSEcCtD
Riluzole—Mental disorder—Methotrexate—systemic lupus erythematosus	8.13e-05	0.000232	CcSEcCtD
Riluzole—Malnutrition—Methotrexate—systemic lupus erythematosus	8.08e-05	0.00023	CcSEcCtD
Riluzole—Hypersensitivity—Prednisolone—systemic lupus erythematosus	8e-05	0.000228	CcSEcCtD
Riluzole—Dyspepsia—Betamethasone—systemic lupus erythematosus	7.98e-05	0.000227	CcSEcCtD
Riluzole—Dyspepsia—Dexamethasone—systemic lupus erythematosus	7.98e-05	0.000227	CcSEcCtD
Riluzole—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	7.97e-05	0.000227	CcSEcCtD
Riluzole—Urticaria—Triamcinolone—systemic lupus erythematosus	7.93e-05	0.000226	CcSEcCtD
Riluzole—Urticaria—Methylprednisolone—systemic lupus erythematosus	7.92e-05	0.000225	CcSEcCtD
Riluzole—Dysgeusia—Methotrexate—systemic lupus erythematosus	7.91e-05	0.000225	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	7.9e-05	0.00927	CbGpPWpGaD
Riluzole—Body temperature increased—Triamcinolone—systemic lupus erythematosus	7.9e-05	0.000225	CcSEcCtD
Riluzole—Dizziness—Cyclosporine—systemic lupus erythematosus	7.89e-05	0.000225	CcSEcCtD
Riluzole—Oedema—Prednisone—systemic lupus erythematosus	7.89e-05	0.000225	CcSEcCtD
Riluzole—Anaphylactic shock—Prednisone—systemic lupus erythematosus	7.89e-05	0.000225	CcSEcCtD
Riluzole—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	7.88e-05	0.000224	CcSEcCtD
Riluzole—Decreased appetite—Betamethasone—systemic lupus erythematosus	7.88e-05	0.000224	CcSEcCtD
Riluzole—Decreased appetite—Dexamethasone—systemic lupus erythematosus	7.88e-05	0.000224	CcSEcCtD
Riluzole—Infection—Prednisone—systemic lupus erythematosus	7.84e-05	0.000223	CcSEcCtD
Riluzole—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	7.82e-05	0.000223	CcSEcCtD
Riluzole—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	7.82e-05	0.000223	CcSEcCtD
Riluzole—Back pain—Methotrexate—systemic lupus erythematosus	7.82e-05	0.000223	CcSEcCtD
Riluzole—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	7.82e-05	0.000223	CcSEcCtD
Riluzole—Fatigue—Betamethasone—systemic lupus erythematosus	7.81e-05	0.000222	CcSEcCtD
Riluzole—Fatigue—Dexamethasone—systemic lupus erythematosus	7.81e-05	0.000222	CcSEcCtD
Riluzole—Shock—Prednisone—systemic lupus erythematosus	7.76e-05	0.000221	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	7.76e-05	0.0091	CbGpPWpGaD
Riluzole—Pain—Betamethasone—systemic lupus erythematosus	7.75e-05	0.000221	CcSEcCtD
Riluzole—Pain—Dexamethasone—systemic lupus erythematosus	7.75e-05	0.000221	CcSEcCtD
Riluzole—Nervous system disorder—Prednisone—systemic lupus erythematosus	7.74e-05	0.00022	CcSEcCtD
Riluzole—Tachycardia—Prednisone—systemic lupus erythematosus	7.7e-05	0.000219	CcSEcCtD
Riluzole—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	7.7e-05	0.000219	CcSEcCtD
Riluzole—Skin disorder—Prednisone—systemic lupus erythematosus	7.67e-05	0.000218	CcSEcCtD
Riluzole—Hyperhidrosis—Prednisone—systemic lupus erythematosus	7.63e-05	0.000217	CcSEcCtD
Riluzole—Asthenia—Hydrocortisone—systemic lupus erythematosus	7.61e-05	0.000217	CcSEcCtD
Riluzole—Vomiting—Cyclosporine—systemic lupus erythematosus	7.59e-05	0.000216	CcSEcCtD
Riluzole—Rash—Cyclosporine—systemic lupus erythematosus	7.53e-05	0.000214	CcSEcCtD
Riluzole—Anorexia—Prednisone—systemic lupus erythematosus	7.52e-05	0.000214	CcSEcCtD
Riluzole—Dermatitis—Cyclosporine—systemic lupus erythematosus	7.52e-05	0.000214	CcSEcCtD
Riluzole—Pruritus—Hydrocortisone—systemic lupus erythematosus	7.5e-05	0.000214	CcSEcCtD
Riluzole—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	7.5e-05	0.000213	CcSEcCtD
Riluzole—Headache—Cyclosporine—systemic lupus erythematosus	7.48e-05	0.000213	CcSEcCtD
Riluzole—Anaemia—Methotrexate—systemic lupus erythematosus	7.47e-05	0.000213	CcSEcCtD
Riluzole—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	7.47e-05	0.000213	CcSEcCtD
Riluzole—Feeling abnormal—Betamethasone—systemic lupus erythematosus	7.47e-05	0.000213	CcSEcCtD
Riluzole—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	7.41e-05	0.000211	CcSEcCtD
Riluzole—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	7.41e-05	0.000211	CcSEcCtD
Riluzole—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	7.4e-05	0.000211	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—CLU—systemic lupus erythematosus	7.4e-05	0.00868	CbGpPWpGaD
Riluzole—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	7.36e-05	0.00021	CcSEcCtD
Riluzole—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	7.34e-05	0.000209	CcSEcCtD
Riluzole—Rash—Mycophenolate mofetil—systemic lupus erythematosus	7.34e-05	0.000209	CcSEcCtD
Riluzole—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	7.33e-05	0.000209	CcSEcCtD
Riluzole—Headache—Mycophenolate mofetil—systemic lupus erythematosus	7.29e-05	0.000208	CcSEcCtD
Riluzole—Malaise—Methotrexate—systemic lupus erythematosus	7.29e-05	0.000208	CcSEcCtD
Riluzole—Vertigo—Methotrexate—systemic lupus erythematosus	7.26e-05	0.000207	CcSEcCtD
Riluzole—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	7.26e-05	0.000207	CcSEcCtD
Riluzole—Leukopenia—Methotrexate—systemic lupus erythematosus	7.23e-05	0.000206	CcSEcCtD
Riluzole—Urticaria—Dexamethasone—systemic lupus erythematosus	7.2e-05	0.000205	CcSEcCtD
Riluzole—Urticaria—Betamethasone—systemic lupus erythematosus	7.2e-05	0.000205	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	7.19e-05	0.000205	CcSEcCtD
Riluzole—Dizziness—Prednisolone—systemic lupus erythematosus	7.18e-05	0.000204	CcSEcCtD
Riluzole—Asthenia—Triamcinolone—systemic lupus erythematosus	7.17e-05	0.000204	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—P2RY12—systemic lupus erythematosus	7.17e-05	0.00841	CbGpPWpGaD
Riluzole—Body temperature increased—Dexamethasone—systemic lupus erythematosus	7.16e-05	0.000204	CcSEcCtD
Riluzole—Body temperature increased—Betamethasone—systemic lupus erythematosus	7.16e-05	0.000204	CcSEcCtD
Riluzole—Abdominal pain—Betamethasone—systemic lupus erythematosus	7.16e-05	0.000204	CcSEcCtD
Riluzole—Abdominal pain—Dexamethasone—systemic lupus erythematosus	7.16e-05	0.000204	CcSEcCtD
Riluzole—Asthenia—Methylprednisolone—systemic lupus erythematosus	7.15e-05	0.000204	CcSEcCtD
Riluzole—Insomnia—Prednisone—systemic lupus erythematosus	7.14e-05	0.000203	CcSEcCtD
Riluzole—Nausea—Cyclosporine—systemic lupus erythematosus	7.09e-05	0.000202	CcSEcCtD
Riluzole—Paraesthesia—Prednisone—systemic lupus erythematosus	7.09e-05	0.000202	CcSEcCtD
Riluzole—Pruritus—Triamcinolone—systemic lupus erythematosus	7.07e-05	0.000201	CcSEcCtD
Riluzole—Cough—Methotrexate—systemic lupus erythematosus	7.05e-05	0.000201	CcSEcCtD
Riluzole—Pruritus—Methylprednisolone—systemic lupus erythematosus	7.05e-05	0.000201	CcSEcCtD
Riluzole—Dizziness—Hydrocortisone—systemic lupus erythematosus	7.01e-05	0.0002	CcSEcCtD
Riluzole—Convulsion—Methotrexate—systemic lupus erythematosus	7e-05	0.000199	CcSEcCtD
Riluzole—Dyspepsia—Prednisone—systemic lupus erythematosus	6.95e-05	0.000198	CcSEcCtD
Riluzole—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	6.92e-05	0.000197	CcSEcCtD
Riluzole—Myalgia—Methotrexate—systemic lupus erythematosus	6.88e-05	0.000196	CcSEcCtD
Riluzole—Chest pain—Methotrexate—systemic lupus erythematosus	6.88e-05	0.000196	CcSEcCtD
Riluzole—Arthralgia—Methotrexate—systemic lupus erythematosus	6.88e-05	0.000196	CcSEcCtD
Riluzole—Decreased appetite—Prednisone—systemic lupus erythematosus	6.86e-05	0.000195	CcSEcCtD
Riluzole—Rash—Prednisolone—systemic lupus erythematosus	6.85e-05	0.000195	CcSEcCtD
Riluzole—Dermatitis—Prednisolone—systemic lupus erythematosus	6.84e-05	0.000195	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	6.83e-05	0.000195	CcSEcCtD
Riluzole—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	6.82e-05	0.000194	CcSEcCtD
Riluzole—Fatigue—Prednisone—systemic lupus erythematosus	6.8e-05	0.000194	CcSEcCtD
Riluzole—Headache—Prednisolone—systemic lupus erythematosus	6.8e-05	0.000194	CcSEcCtD
Riluzole—Discomfort—Methotrexate—systemic lupus erythematosus	6.8e-05	0.000194	CcSEcCtD
Riluzole—Constipation—Prednisone—systemic lupus erythematosus	6.75e-05	0.000192	CcSEcCtD
Riluzole—Vomiting—Hydrocortisone—systemic lupus erythematosus	6.74e-05	0.000192	CcSEcCtD
Riluzole—Rash—Hydrocortisone—systemic lupus erythematosus	6.69e-05	0.00019	CcSEcCtD
Riluzole—Dermatitis—Hydrocortisone—systemic lupus erythematosus	6.68e-05	0.00019	CcSEcCtD
Riluzole—Confusional state—Methotrexate—systemic lupus erythematosus	6.65e-05	0.000189	CcSEcCtD
Riluzole—Headache—Hydrocortisone—systemic lupus erythematosus	6.65e-05	0.000189	CcSEcCtD
Riluzole—Dizziness—Triamcinolone—systemic lupus erythematosus	6.6e-05	0.000188	CcSEcCtD
Riluzole—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	6.6e-05	0.000188	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—SELE—systemic lupus erythematosus	6.59e-05	0.00774	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—CSK—systemic lupus erythematosus	6.59e-05	0.00774	CbGpPWpGaD
Riluzole—Dizziness—Methylprednisolone—systemic lupus erythematosus	6.59e-05	0.000188	CcSEcCtD
Riluzole—Infection—Methotrexate—systemic lupus erythematosus	6.55e-05	0.000187	CcSEcCtD
Riluzole—Feeling abnormal—Prednisone—systemic lupus erythematosus	6.5e-05	0.000185	CcSEcCtD
Riluzole—Asthenia—Dexamethasone—systemic lupus erythematosus	6.5e-05	0.000185	CcSEcCtD
Riluzole—Asthenia—Betamethasone—systemic lupus erythematosus	6.5e-05	0.000185	CcSEcCtD
Riluzole—Nervous system disorder—Methotrexate—systemic lupus erythematosus	6.47e-05	0.000184	CcSEcCtD
Riluzole—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	6.46e-05	0.000184	CcSEcCtD
Riluzole—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	6.45e-05	0.000184	CcSEcCtD
Riluzole—Nausea—Prednisolone—systemic lupus erythematosus	6.45e-05	0.000184	CcSEcCtD
Riluzole—Pruritus—Dexamethasone—systemic lupus erythematosus	6.41e-05	0.000183	CcSEcCtD
Riluzole—Pruritus—Betamethasone—systemic lupus erythematosus	6.41e-05	0.000183	CcSEcCtD
Riluzole—Skin disorder—Methotrexate—systemic lupus erythematosus	6.41e-05	0.000182	CcSEcCtD
Riluzole—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	6.38e-05	0.000182	CcSEcCtD
Riluzole—Vomiting—Triamcinolone—systemic lupus erythematosus	6.35e-05	0.000181	CcSEcCtD
Riluzole—Vomiting—Methylprednisolone—systemic lupus erythematosus	6.34e-05	0.00018	CcSEcCtD
Riluzole—Nausea—Hydrocortisone—systemic lupus erythematosus	6.3e-05	0.000179	CcSEcCtD
Riluzole—Rash—Triamcinolone—systemic lupus erythematosus	6.3e-05	0.000179	CcSEcCtD
Riluzole—Dermatitis—Triamcinolone—systemic lupus erythematosus	6.29e-05	0.000179	CcSEcCtD
Riluzole—Anorexia—Methotrexate—systemic lupus erythematosus	6.29e-05	0.000179	CcSEcCtD
Riluzole—Rash—Methylprednisolone—systemic lupus erythematosus	6.28e-05	0.000179	CcSEcCtD
Riluzole—Dermatitis—Methylprednisolone—systemic lupus erythematosus	6.28e-05	0.000179	CcSEcCtD
Riluzole—Urticaria—Prednisone—systemic lupus erythematosus	6.27e-05	0.000179	CcSEcCtD
Riluzole—Headache—Triamcinolone—systemic lupus erythematosus	6.26e-05	0.000178	CcSEcCtD
Riluzole—Headache—Methylprednisolone—systemic lupus erythematosus	6.24e-05	0.000178	CcSEcCtD
Riluzole—Abdominal pain—Prednisone—systemic lupus erythematosus	6.24e-05	0.000178	CcSEcCtD
Riluzole—Body temperature increased—Prednisone—systemic lupus erythematosus	6.24e-05	0.000178	CcSEcCtD
Riluzole—Diarrhoea—Dexamethasone—systemic lupus erythematosus	6.2e-05	0.000177	CcSEcCtD
Riluzole—Diarrhoea—Betamethasone—systemic lupus erythematosus	6.2e-05	0.000177	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—ITGAM—systemic lupus erythematosus	6.2e-05	0.00728	CbGpPWpGaD
Riluzole—Hypotension—Methotrexate—systemic lupus erythematosus	6.16e-05	0.000175	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	6.01e-05	0.000171	CcSEcCtD
Riluzole—Dizziness—Dexamethasone—systemic lupus erythematosus	5.99e-05	0.000171	CcSEcCtD
Riluzole—Dizziness—Betamethasone—systemic lupus erythematosus	5.99e-05	0.000171	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—LYN—systemic lupus erythematosus	5.99e-05	0.00703	CbGpPWpGaD
Riluzole—Insomnia—Methotrexate—systemic lupus erythematosus	5.97e-05	0.00017	CcSEcCtD
Riluzole—Nausea—Triamcinolone—systemic lupus erythematosus	5.93e-05	0.000169	CcSEcCtD
Riluzole—Paraesthesia—Methotrexate—systemic lupus erythematosus	5.92e-05	0.000169	CcSEcCtD
Riluzole—Nausea—Methylprednisolone—systemic lupus erythematosus	5.92e-05	0.000169	CcSEcCtD
Riluzole—Dyspnoea—Methotrexate—systemic lupus erythematosus	5.88e-05	0.000167	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—SH2B3—systemic lupus erythematosus	5.88e-05	0.0069	CbGpPWpGaD
Riluzole—Somnolence—Methotrexate—systemic lupus erythematosus	5.86e-05	0.000167	CcSEcCtD
Riluzole—Hypersensitivity—Prednisone—systemic lupus erythematosus	5.81e-05	0.000166	CcSEcCtD
Riluzole—Dyspepsia—Methotrexate—systemic lupus erythematosus	5.81e-05	0.000165	CcSEcCtD
Riluzole—Vomiting—Dexamethasone—systemic lupus erythematosus	5.76e-05	0.000164	CcSEcCtD
Riluzole—Vomiting—Betamethasone—systemic lupus erythematosus	5.76e-05	0.000164	CcSEcCtD
Riluzole—Decreased appetite—Methotrexate—systemic lupus erythematosus	5.73e-05	0.000163	CcSEcCtD
Riluzole—Rash—Dexamethasone—systemic lupus erythematosus	5.71e-05	0.000163	CcSEcCtD
Riluzole—Rash—Betamethasone—systemic lupus erythematosus	5.71e-05	0.000163	CcSEcCtD
Riluzole—Dermatitis—Dexamethasone—systemic lupus erythematosus	5.71e-05	0.000163	CcSEcCtD
Riluzole—Dermatitis—Betamethasone—systemic lupus erythematosus	5.71e-05	0.000163	CcSEcCtD
Riluzole—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	5.69e-05	0.000162	CcSEcCtD
Riluzole—Fatigue—Methotrexate—systemic lupus erythematosus	5.69e-05	0.000162	CcSEcCtD
Riluzole—SCN5A—nervous system—systemic lupus erythematosus	5.69e-05	0.0484	CbGeAlD
Riluzole—Headache—Dexamethasone—systemic lupus erythematosus	5.68e-05	0.000162	CcSEcCtD
Riluzole—Headache—Betamethasone—systemic lupus erythematosus	5.68e-05	0.000162	CcSEcCtD
Riluzole—Asthenia—Prednisone—systemic lupus erythematosus	5.66e-05	0.000161	CcSEcCtD
Riluzole—Pain—Methotrexate—systemic lupus erythematosus	5.64e-05	0.000161	CcSEcCtD
Riluzole—CYP1A1—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.6e-05	0.00657	CbGpPWpGaD
Riluzole—Pruritus—Prednisone—systemic lupus erythematosus	5.58e-05	0.000159	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	5.55e-05	0.00652	CbGpPWpGaD
Riluzole—SCN5A—central nervous system—systemic lupus erythematosus	5.47e-05	0.0466	CbGeAlD
Riluzole—Feeling abnormal—Methotrexate—systemic lupus erythematosus	5.44e-05	0.000155	CcSEcCtD
Riluzole—Diarrhoea—Prednisone—systemic lupus erythematosus	5.4e-05	0.000154	CcSEcCtD
Riluzole—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	5.39e-05	0.000154	CcSEcCtD
Riluzole—ABCG2—nephron tubule—systemic lupus erythematosus	5.39e-05	0.0459	CbGeAlD
Riluzole—Nausea—Dexamethasone—systemic lupus erythematosus	5.38e-05	0.000153	CcSEcCtD
Riluzole—Nausea—Betamethasone—systemic lupus erythematosus	5.38e-05	0.000153	CcSEcCtD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—EP300—systemic lupus erythematosus	5.38e-05	0.00632	CbGpPWpGaD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—TGFB1—systemic lupus erythematosus	5.37e-05	0.0063	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	5.32e-05	0.00624	CbGpPWpGaD
Riluzole—Urticaria—Methotrexate—systemic lupus erythematosus	5.24e-05	0.000149	CcSEcCtD
Riluzole—Dizziness—Prednisone—systemic lupus erythematosus	5.22e-05	0.000149	CcSEcCtD
Riluzole—Body temperature increased—Methotrexate—systemic lupus erythematosus	5.21e-05	0.000148	CcSEcCtD
Riluzole—Abdominal pain—Methotrexate—systemic lupus erythematosus	5.21e-05	0.000148	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	5.14e-05	0.00603	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	5.11e-05	0.006	CbGpPWpGaD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—systemic lupus erythematosus	5.1e-05	0.00598	CbGpPWpGaD
Riluzole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	5.09e-05	0.00598	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—LYN—systemic lupus erythematosus	5.07e-05	0.00595	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	5.04e-05	0.00591	CbGpPWpGaD
Riluzole—Vomiting—Prednisone—systemic lupus erythematosus	5.02e-05	0.000143	CcSEcCtD
Riluzole—Rash—Prednisone—systemic lupus erythematosus	4.98e-05	0.000142	CcSEcCtD
Riluzole—Dermatitis—Prednisone—systemic lupus erythematosus	4.97e-05	0.000142	CcSEcCtD
Riluzole—Headache—Prednisone—systemic lupus erythematosus	4.94e-05	0.000141	CcSEcCtD
Riluzole—Hypersensitivity—Methotrexate—systemic lupus erythematosus	4.86e-05	0.000138	CcSEcCtD
Riluzole—CYP1A1—skin of body—systemic lupus erythematosus	4.77e-05	0.0406	CbGeAlD
Riluzole—Asthenia—Methotrexate—systemic lupus erythematosus	4.73e-05	0.000135	CcSEcCtD
Riluzole—Nausea—Prednisone—systemic lupus erythematosus	4.69e-05	0.000133	CcSEcCtD
Riluzole—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	4.69e-05	0.0055	CbGpPWpGaD
Riluzole—Pruritus—Methotrexate—systemic lupus erythematosus	4.67e-05	0.000133	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—IFNA1—systemic lupus erythematosus	4.62e-05	0.00542	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	4.57e-05	0.00537	CbGpPWpGaD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.54e-05	0.00533	CbGpPWpGaD
Riluzole—Diarrhoea—Methotrexate—systemic lupus erythematosus	4.51e-05	0.000128	CcSEcCtD
Riluzole—CYP1A1—kidney—systemic lupus erythematosus	4.5e-05	0.0383	CbGeAlD
Riluzole—SLC7A11—Hemostasis—RASGRP1—systemic lupus erythematosus	4.5e-05	0.00528	CbGpPWpGaD
Riluzole—Dizziness—Methotrexate—systemic lupus erythematosus	4.36e-05	0.000124	CcSEcCtD
Riluzole—SCN5A—Axon guidance—PTPRC—systemic lupus erythematosus	4.34e-05	0.0051	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—NAT2—systemic lupus erythematosus	4.3e-05	0.00505	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.24e-05	0.00498	CbGpPWpGaD
Riluzole—Vomiting—Methotrexate—systemic lupus erythematosus	4.19e-05	0.000119	CcSEcCtD
Riluzole—Rash—Methotrexate—systemic lupus erythematosus	4.16e-05	0.000118	CcSEcCtD
Riluzole—Dermatitis—Methotrexate—systemic lupus erythematosus	4.16e-05	0.000118	CcSEcCtD
Riluzole—Headache—Methotrexate—systemic lupus erythematosus	4.13e-05	0.000118	CcSEcCtD
Riluzole—SLC7A11—NRF2 pathway—TGFB1—systemic lupus erythematosus	4.03e-05	0.00473	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	4.01e-05	0.00471	CbGpPWpGaD
Riluzole—Nausea—Methotrexate—systemic lupus erythematosus	3.92e-05	0.000112	CcSEcCtD
Riluzole—ABCG2—bone marrow—systemic lupus erythematosus	3.71e-05	0.0315	CbGeAlD
Riluzole—SCN5A—Developmental Biology—LYN—systemic lupus erythematosus	3.62e-05	0.00425	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.59e-05	0.00421	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	3.59e-05	0.00421	CbGpPWpGaD
Riluzole—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	3.57e-05	0.00419	CbGpPWpGaD
Riluzole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	3.55e-05	0.00417	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—JAK1—systemic lupus erythematosus	3.49e-05	0.00409	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—RXRA—systemic lupus erythematosus	3.45e-05	0.00405	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	3.44e-05	0.00404	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	3.37e-05	0.00396	CbGpPWpGaD
Riluzole—ABCG2—lung—systemic lupus erythematosus	3.36e-05	0.0286	CbGeAlD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	3.26e-05	0.00382	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	3.26e-05	0.00382	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IL2RA—systemic lupus erythematosus	3.26e-05	0.00382	CbGpPWpGaD
Riluzole—CYP1A2—lung—systemic lupus erythematosus	3.23e-05	0.0275	CbGeAlD
Riluzole—CYP1A1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.22e-05	0.00378	CbGpPWpGaD
Riluzole—CYP1A1—lung—systemic lupus erythematosus	3.19e-05	0.0271	CbGeAlD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	3.19e-05	0.00374	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	3.17e-05	0.00372	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PTPRC—systemic lupus erythematosus	3.1e-05	0.00364	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	3.01e-05	0.00353	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	3e-05	0.00352	CbGpPWpGaD
Riluzole—CYP1A1—nervous system—systemic lupus erythematosus	2.95e-05	0.0251	CbGeAlD
Riluzole—SCN5A—Axon guidance—JAK1—systemic lupus erythematosus	2.95e-05	0.00347	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—ADIPOQ—systemic lupus erythematosus	2.92e-05	0.00343	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	2.89e-05	0.0034	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	2.86e-05	0.00336	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.86e-05	0.00336	CbGpPWpGaD
Riluzole—CYP1A1—central nervous system—systemic lupus erythematosus	2.84e-05	0.0242	CbGeAlD
Riluzole—SLC7A11—Hemostasis—F2—systemic lupus erythematosus	2.84e-05	0.00333	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	2.74e-05	0.00322	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.71e-05	0.00318	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	2.7e-05	0.00317	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	2.6e-05	0.00305	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—RXRA—systemic lupus erythematosus	2.51e-05	0.00294	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	2.49e-05	0.00292	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	2.46e-05	0.00289	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—RXRA—systemic lupus erythematosus	2.41e-05	0.00283	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—ALB—systemic lupus erythematosus	2.35e-05	0.00276	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	2.32e-05	0.00273	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	2.32e-05	0.00273	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.32e-05	0.00273	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	2.29e-05	0.00268	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—NOS3—systemic lupus erythematosus	2.25e-05	0.00264	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	2.19e-05	0.00257	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—PPARG—systemic lupus erythematosus	2.18e-05	0.00255	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	2.13e-05	0.0025	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	2.11e-05	0.00248	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—JAK1—systemic lupus erythematosus	2.11e-05	0.00247	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	2.08e-05	0.00244	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	2.08e-05	0.00244	CbGpPWpGaD
Riluzole—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.05e-05	0.00241	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.04e-05	0.00239	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	2.03e-05	0.00239	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—TYK2—systemic lupus erythematosus	1.94e-05	0.00228	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	1.92e-05	0.00225	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IL2—systemic lupus erythematosus	1.91e-05	0.00224	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	1.82e-05	0.00214	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	1.82e-05	0.00214	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	1.73e-05	0.00203	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—EP300—systemic lupus erythematosus	1.71e-05	0.00201	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.7e-05	0.002	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—VEGFA—systemic lupus erythematosus	1.62e-05	0.0019	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	1.59e-05	0.00186	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PPARG—systemic lupus erythematosus	1.58e-05	0.00186	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	1.54e-05	0.0018	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MMP9—systemic lupus erythematosus	1.53e-05	0.0018	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TGFB1—systemic lupus erythematosus	1.49e-05	0.00175	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	1.48e-05	0.00174	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	1.48e-05	0.00174	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	1.47e-05	0.00172	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—EP300—systemic lupus erythematosus	1.42e-05	0.00167	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	1.39e-05	0.00164	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TYK2—systemic lupus erythematosus	1.39e-05	0.00163	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—VEGFA—systemic lupus erythematosus	1.37e-05	0.00161	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.3e-05	0.00153	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP9—systemic lupus erythematosus	1.09e-05	0.00128	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	1.09e-05	0.00128	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—EP300—systemic lupus erythematosus	1.03e-05	0.00121	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—VEGFA—systemic lupus erythematosus	9.8e-06	0.00115	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	9.6e-06	0.00113	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—IL6—systemic lupus erythematosus	9.5e-06	0.00112	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.26e-06	0.00109	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TGFB1—systemic lupus erythematosus	9e-06	0.00106	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TNF—systemic lupus erythematosus	8.4e-06	0.000986	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.38e-06	0.000867	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	7.35e-06	0.000863	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—IL6—systemic lupus erythematosus	6.78e-06	0.000796	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	6.09e-06	0.000715	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.9e-06	0.000693	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.84e-06	0.000686	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.26e-06	0.000617	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	4.69e-06	0.00055	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.6e-06	0.00054	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	4.12e-06	0.000484	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	3.85e-06	0.000451	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.82e-06	0.000449	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.73e-06	0.000437	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALB—systemic lupus erythematosus	3.46e-06	0.000406	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.35e-06	0.000393	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	3.31e-06	0.000388	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	3.03e-06	0.000355	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.93e-06	0.000344	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	2.63e-06	0.000309	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	2.6e-06	0.000306	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—EP300—systemic lupus erythematosus	2.52e-06	0.000295	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.44e-06	0.000286	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	2.34e-06	0.000275	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	2.24e-06	0.000263	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	2.05e-06	0.00024	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	1.7e-06	0.0002	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	1.66e-06	0.000195	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.49e-06	0.000175	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.43e-06	0.000168	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.31e-06	0.000153	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.09e-06	0.000127	CbGpPWpGaD
